← Feed

POON CHRISTINE A

SEC Form 4 insider
PRUDENTIAL FINANCIAL INC ($PRU), REGENERON PHARMACEUTICALS, INC. ($REGN)
1 thesis · first seen Sep 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$REGNSEC Form 4bearish
POON CHRISTINE A · REGENERON PHARMACEUTICALS, INC. · 5h agono track record yet
Sold 7,830 @ $969.09 avg · $7,587,958 · 2026-11-02

Form 4: POON CHRISTINE A sold REGN

POON CHRISTINE A (Director at REGENERON PHARMACEUTICALS, INC.) reported an open-market sale of 7,830 shares of REGN at an average $969.09, roughly $7,587,958, in a Form 4 filed 2026-11-04.

At post $930.67Now $946.89+1.7% since postedas of Nov 4, 2:15 PM ET
View filing on SEC.gov →

End of results.